Oncotarget
The cover for issue 28 of Oncotarget features Figure 5, "TMEM165 expression levels alters N-linked glycosylation," by Murali, et al.
Development and comprehensive characterization of porcine hepatocellular carcinoma for translational liver cancer investigation |
https://doi.org/10.18632/oncotarget.27647 Ron C. Gaba, Lobna Elkhadragy, F. Edward Boas, Sulalita Chaki, Hanna H. Chen, Mohammed El-Kebir, Kelly D. Garcia, Eileena F. Giurini, Grace Guzman, Francesca V. LoBianco, Mario F. Neto, Jordan L. Newson, Aisha Qazi, Maureen Regan, Lauretta A. Rund, Regina M. Schwind, Matthew C. Stewart, Faith M. Thomas, Herbert E. Whiteley, Jiaqi Wu, Lawrence B. Schook, and Kyle M. Schachtschneider |
2686-2701 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Lipid and protein tumor markers for head and neck squamous cell carcinoma identified by imaging mass spectrometry |
https://doi.org/10.18632/oncotarget.27649 Janos Schmidt, Béla Kajtár, Kata Juhász, Mária Péter, Tamás Járai, András Burián, László Kereskai, Imre Gerlinger, Tamás Tornóczki, Gábor Balogh, László Vígh, Lászó Márk, and Zsolt Balogi |
2702-2717 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Podcast | Order a Reprint |
Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice |
https://doi.org/10.18632/oncotarget.27660 Eugenia Y. Xu, Evan Vosburgh, Chung Wong, Laura H. Tang, and Daniel A. Notterman |
2718-2739 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Rapid onset type 1 diabetes with anti-PD-1 directed therapy |
https://doi.org/10.18632/oncotarget.27665 Karen Yun, Gregory Daniels, Kathryn Gold, Karen Mccowen, and Sandip Pravin Patel |
2740-2746 |
Abstract | PDF | Full Text | How to cite | Press Release | Order a Reprint |
Novel role for the Golgi membrane protein TMEM165 in control of migration and invasion for breast carcinoma |
https://doi.org/10.18632/oncotarget.27668 Pavitra Murali, Blake P. Johnson, Zhongpeng Lu, Leslie Climer, Danielle A. Scott, Francois Foulquier, Gabriela Oprea-Ilies, Vladimir Lupashin, Richard R. Drake, and Karen L. Abbott |
2747-2762 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Podcast | Order a Reprint |
Can Denosumab be used in combination with Doxorubicin in Osteosarcoma? |
https://doi.org/10.18632/oncotarget.27669 Francesca Punzo, Chiara Tortora, Maura Argenziano, Daniela Di Pinto, Elvira Pota, Martina Di Martino, Alessandra Di Paola, and Francesca Rossi |
2763-2773 |
Abstract | PDF | Full Text | How to cite | Press Release | Order a Reprint |
Working together for the family: determination of HER oncogene co-amplifications in breast cancer |
https://doi.org/10.18632/oncotarget.27671 Sergio Laurito, María Teresita Branham, Emanuel Campoy, Sebastián Real, Juan Cueto, Guillermo Urrutia, Francisco Gago, Olga Tello, Telma Glatstein, Paola De la Iglesia, Lilit Atanesyan, Suvi Savola, and Maria Roqué |
2774-2792 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Triptolide-induced apoptosis in non-small cell lung cancer via a novel miR204-5p/Caveolin-1/Akt-mediated pathway |
https://doi.org/10.18632/oncotarget.27672 Brian J. Philips, Ajay Kumar, Sarah Burki, John P. Ryan, Kentaro Noda, and Jonathan D’Cunha |
2793-2806 |
Abstract | PDF | Full Text | How to cite | Press Release | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC